ADMINISTRATION REGIMEN OF H+, K+ -ATPASE INHIBITORS

摘要

PURPOSE: A new administration regimen is provided which gives an extended plasma concentration profile of a H+, K+ -ATPase inhibitor. CONSTITUTION: An extended plasma profile is received by two or more consecutive administrations of a unit dose of a H+, K+ -ATPase with 0.5-4 hours interval or by a pharmaceutical composition with extended release, which may be administered once daily.